The Clorox Company (NYSE:CLX - Get Free Report) reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $171.37 and last traded at $169.95, with a volume of 97704 shares traded. The stock had previously closed at $169.74.
Analysts Set New Price Targets
Several research firms have issued reports on CLX. Evercore ISI dropped their target price on Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research report on Monday, October 14th. Barclays boosted their target price on Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research report on Friday, November 1st. TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and boosted their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. BNP Paribas upgraded Clorox to a "strong sell" rating in a report on Friday, September 6th. Finally, JPMorgan Chase & Co. upped their price target on Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a report on Friday, October 11th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $155.00.
Get Our Latest Analysis on CLX
Clorox Stock Down 1.6 %
The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $20.67 billion, a PE ratio of 58.18, a price-to-earnings-growth ratio of 3.10 and a beta of 0.42. The firm has a 50-day moving average of $163.50 and a two-hundred day moving average of $150.49.
Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company posted $0.49 EPS. The business's quarterly revenue was up 27.0% on a year-over-year basis. On average, equities research analysts forecast that The Clorox Company will post 6.85 EPS for the current year.
Clorox Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 2.92%. Clorox's dividend payout ratio is presently 170.04%.
Institutional Trading of Clorox
Large investors have recently modified their holdings of the business. Gateway Investment Advisers LLC grew its stake in Clorox by 92.7% in the second quarter. Gateway Investment Advisers LLC now owns 8,337 shares of the company's stock worth $1,138,000 after purchasing an additional 4,011 shares in the last quarter. Diversify Advisory Services LLC lifted its holdings in Clorox by 3.9% in the second quarter. Diversify Advisory Services LLC now owns 2,441 shares of the company's stock worth $322,000 after acquiring an additional 92 shares during the last quarter. Czech National Bank lifted its holdings in Clorox by 8.4% in the second quarter. Czech National Bank now owns 23,665 shares of the company's stock worth $3,230,000 after acquiring an additional 1,829 shares during the last quarter. RFG Advisory LLC lifted its holdings in Clorox by 17.6% in the second quarter. RFG Advisory LLC now owns 3,337 shares of the company's stock worth $455,000 after acquiring an additional 500 shares during the last quarter. Finally, Insight Advisors LLC PA lifted its holdings in Clorox by 8.2% in the second quarter. Insight Advisors LLC PA now owns 4,057 shares of the company's stock worth $554,000 after acquiring an additional 308 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Clorox Company Profile
(
Get Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
